HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | -100.0% | 3,200 | -74.6% | 0.00% | -100.0% |
| Q4 2020 | $70,000 | +3400.0% | 12,600 | +37.0% | 0.00% | – |
| Q2 2020 | $2,000 | -99.8% | 9,200 | -56.6% | 0.00% | -100.0% |
| Q3 2019 | $1,244,000 | +31000.0% | 21,200 | +253.3% | 0.11% | – |
| Q3 2017 | $4,000 | -84.0% | 6,000 | +844.9% | 0.00% | -100.0% |
| Q4 2016 | $25,000 | – | 635 | +27.0% | 0.00% | – |
| Q1 2016 | $0 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |